Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Amir Reza Moravejolahkami, Ahmad Chitsaz, Akbar Hassanzadeh & Zamzam Paknahad. (2022) Effects of anti-Inflammatory-antioxidant-rich diet and co-supplemented synbiotics intervention in patients with progressive forms of multiple sclerosis: a single-center, single-blind randomized clinical trial. Nutritional Neuroscience 0:0, pages 1-12.
Read now
Read now
Behnaz Pourrajab, Somaye Fatahi, Mohammad Hassan Sohouli, Mihnea-Alexandru Găman & Farzad Shidfar. (2022) The effects of probiotic/synbiotic supplementation compared to placebo on biomarkers of oxidative stress in adults: a systematic review and meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition 62:2, pages 490-507.
Read now
Read now
Lorrie L. Blais, Theresa L. Montgomery, Eyal Amiel, Paula B. Deming & Dimitry N. Krementsov. (2021) Probiotic and commensal gut microbial therapies in multiple sclerosis and its animal models: a comprehensive review. Gut Microbes 13:1.
Read now
Read now
Articles from other publishers (60)
Saeede Saadati, Kaveh Naseri, Omid Asbaghi, Mohsen Yousefi, Elnaz Golalipour & Barbora de Courten. (2023) Beneficial effects of the probiotics and synbiotics supplementation on anthropometric indices and body composition in adults: A systematic review and meta‐analysis. Obesity Reviews.
Crossref
Crossref
Sarmistha Mitra, Raju Dash, Amena Al Nishan, Sarmin Ummey Habiba & Il Soo Moon. (2023) Brain modulation by the gut microbiota: From disease to therapy. Journal of Advanced Research 53, pages 153-173.
Crossref
Crossref
Amir Reza Moravejolahkami, Ahmad Chitsaz, Akbar Hassanzadeh & Zamzam Paknahad. (2023) Anti-inflammatory-antioxidant modifications and synbiotics improved health-related conditions in patients with progressive forms of multiple sclerosis: A single-center, randomized clinical trial. Complementary Therapies in Clinical Practice 53, pages 101794.
Crossref
Crossref
María Torres‑Chávez, Nora Torres‑Carrillo, Ana Moreal‑Lugo, Sandra Garnés‑Rancurello, Selvasankar Murugesan, Itzae Gutiérrez‑Hurtado, Jesús Beltrán‑Ramírez, Elena Sandoval‑Pinto & Norma Torres‑Carrillo. (2023) Association of intestinal dysbiosis with susceptibility to multiple sclerosis: Evidence from different population studies (Review). Biomedical Reports 19:6.
Crossref
Crossref
Natascia Rinaldo, Alba Pasini, Sofia Straudi, Giovanni Piva, Anna Crepaldi, Andrea Baroni, Lorenzo Caruso, Fabio Manfredini & Nicola Lamberti. (2023) Effects of Exercise, Rehabilitation, and Nutritional Approaches on Body Composition and Bone Density in People with Multiple Sclerosis: A Systematic Review and Meta-Analysis. Journal of Functional Morphology and Kinesiology 8:3, pages 132.
Crossref
Crossref
Weiliang Zhang, Qiang Jia, Mingming Han, Xin Zhang, Limin Guo, Shichao Sun, Wenhui Yin, Cunxiang Bo, Ru Han & Linlin Sai. (2023) Bifidobacteria in disease: from head to toe. Folia Microbiologica.
Crossref
Crossref
Nima Hasaniani, Maryam Ghasemi-Kasman, Mehrdad Halaji & Sahar Rostami-Mansoor. (2023) Bifidobacterium breve Probiotic Compared to Lactobacillus casei Causes a Better Reduction in Demyelination and Oxidative Stress in Cuprizone-Induced Demyelination Model of Rat. Molecular Neurobiology.
Crossref
Crossref
Nirav Yogesh Bhatia, Manjiri Prabhakar Jalgaonkar, Anuja Balu Hargude, Atul P. Sherje, Manisha Jignesh Oza & Gaurav Mahesh Doshi. (2023) Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our
Mental Health. CNS & Neurological Disorders - Drug Targets 22:7, pages 1008-1030.
Crossref
Crossref
Amjad Samara, Claudia Cantoni, Laura Piccio, Anne H. Cross & Salim Chahin. (2023) Obesity, gut microbiota, and multiple sclerosis: Unraveling the connection. Multiple Sclerosis and Related Disorders 76, pages 104768.
Crossref
Crossref
Bahram Moazzami, Shahla Chaichian, Banafsheh Nikfar & Sepideh Arbabi Bidgoli. (2023) Modulation of microRNAs expression and cellular signaling pathways through curcumin as a potential therapeutical approach against ovarian cancer: A review. Pathology - Research and Practice 247, pages 154527.
Crossref
Crossref
Amir Reza Moravejolahkami, Mehdi Shakibaei, Andrea Mary Fairley & Manoj Sharma. (2023) Probiotics, prebiotics, and synbiotics in type 1 diabetes mellitus: A systematic review and meta‐analysis of clinical trials. Diabetes/Metabolism Research and Reviews.
Crossref
Crossref
Cory I. Wasser, Emily-Clare Mercieca, Geraldine Kong, Anthony J. Hannan, Brianna Allford, Sonja J. McKeown, Julie C. Stout & Yifat Glikmann-Johnston. (2023) A Randomized Controlled Trial of Probiotics Targeting Gut Dysbiosis in Huntington’s Disease. Journal of Huntington's Disease 12:1, pages 43-55.
Crossref
Crossref
Chuanqi Chu, Leilei Yu, Yiwen Li, Hang Guo, Qixiao Zhai, Wei Chen & Fengwei Tian. (2023) Meta-analysis of randomized controlled trials of the effects of probiotics in Parkinson's disease. Food & Function 14:8, pages 3406-3422.
Crossref
Crossref
Chiara Salvesi, Stefania Silvi, Dennis Fiorini, Laura Alessandroni, Gianni Sagratini, Francesco Alessandro Palermo, Renato De Leone, Nadaniela Egidi, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura, Amedeo Amedei, Elena Niccolai, Francesca Scocchera, Fausto Mannucci, Valerio Valeriani, Marco Malavasi, Sara Servili, Andrea Casula, Andrea Cresci, Ivano Corradetti, Maria Magdalena Coman & M. Cristina Verdenelli. (2023) Six-Month Synbio® Administration Affects Nutritional and Inflammatory Parameters of Older Adults Included in the PROBIOSENIOR Project. Microorganisms 11:3, pages 801.
Crossref
Crossref
Ming-Liang Zhang, Wei-Xia Li, Xiao-Yan Wang, Ya-Li Wu, Xiao-Fei Chen, Hui Zhang, Liu-Qing Yang, Cheng-Zhao Wu, Shu-Qi Zhang, Yu-Long Chen, Ke-Ran Feng, Bin Wang, Lu Niu, De-Xin Kong & Jin-Fa Tang. (2023) Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Theresa L. Montgomery, Korin Eckstrom, Katarina H. Lile, Sydney Caldwell, Eamonn R. Heney, Karolyn G. Lahue, Angelo D’Alessandro, Matthew J. Wargo & Dimitry N. Krementsov. (2022) Lactobacillus reuteri tryptophan metabolism promotes host susceptibility to CNS autoimmunity. Microbiome 10:1.
Crossref
Crossref
Angela Dziedzic & Joanna Saluk. (2022) Probiotics and Commensal Gut Microbiota as the Effective Alternative Therapy for Multiple Sclerosis Patients Treatment. International Journal of Molecular Sciences 23:22, pages 14478.
Crossref
Crossref
Paola Bianchimano, Graham J. Britton, David S. Wallach, Emma M. Smith, Laura M. Cox, Shirong Liu, Kacper Iwanowski, Howard L. Weiner, Jeremiah J. Faith, Jose C. Clemente & Stephanie K. Tankou. (2022) Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis. Microbiome 10:1.
Crossref
Crossref
Mehran Rahimlou, Shima Nematollahi, Durdana Husain, Nasrin Banaei-Jahromi, Nastaran Majdinasab & Seyed Ahmad Hosseini. (2022) Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial. Frontiers in Neuroscience 16.
Crossref
Crossref
Aleksandra Obuchowska, Kamila Gorczyca, Arkadiusz Standyło, Karolina Obuchowska, Żaneta Kimber-Trojnar, Magdalena Wierzchowska-Opoka & Bożena Leszczyńska-Gorzelak. (2022) Effects of Probiotic Supplementation during Pregnancy on the Future Maternal Risk of Metabolic Syndrome. International Journal of Molecular Sciences 23:15, pages 8253.
Crossref
Crossref
Gael Urait Varela-Trinidad, Carolina Domínguez-Díaz, Karla Solórzano-Castanedo, Liliana Íñiguez-Gutiérrez, Teresita de Jesús Hernández-Flores & Mary Fafutis-Morris. (2022) Probiotics: Protecting Our Health from the Gut. Microorganisms 10:7, pages 1428.
Crossref
Crossref
Masoud Soheili, Azam Alinaghipour & Mahmoud Salami. (2022) Good bacteria, oxidative stress and neurological disorders: Possible therapeutical considerations. Life Sciences 301, pages 120605.
Crossref
Crossref
Anjali Kandiruthi Ravi & Saradhadevi Kuppusami Muthukrishnan. (2021) Combination of Probiotics and Natural Compounds to Treat Multiple Sclerosis via Warburg Effect. Advanced Pharmaceutical Bulletin 12:3, pages 515-523.
Crossref
Crossref
Zahra Elahianfiroz, Majid Baseri Salehi & Masood Ghane. (2022) Study of intestinal microbial flora of local chickens to investigate the effect of probiotics Bacillus subtilis and Bacillus coagulans on the expression of ctxM and luxS pathogenic genes in isolates of Escherichia coli. Pharmacia 69:2, pages 453-457.
Crossref
Crossref
Ragaa A. Hamouda, Hanafy A. Hamza, Mohammed L. Salem, Shymaa Kamal, Reem Hasaballah Alhasani, Ifat Alsharif, Hoda Mahrous & Asmaa Abdella. (2022) Synergistic Hypolipidemic and Immunomodulatory Activity of Lactobacillus and Spirulina platensis. Fermentation 8:5, pages 220.
Crossref
Crossref
Hatice Aygun, Ali Tuğrul Akin, Nildem Kızılaslan, Orhan Sumbul & Derya Karabulut. (2022) Electrophysiological, histopathological, and biochemical evaluation of the protective effect of probiotic supplementation against pentylenetetrazole‐induced seizures in rats. European Journal of Neurology.
Crossref
Crossref
John Michael S. Sanchez, Ana Beatriz DePaula-Silva, Jane E. Libbey & Robert S. Fujinami. (2022) Role of diet in regulating the gut microbiota and multiple sclerosis. Clinical Immunology 235, pages 108379.
Crossref
Crossref
Salehe Sabouri, Mahdi Esmailzadeh, Afsaneh Sadeghinejad, Mahin Eslami Shahrbabaki, Gholamreza Asadikaram & Naemeh Nikvarz. (2022) The Effect of Adjunctive Probiotics on Markers of Inflammation and Oxidative Stress in Bipolar Disorder: A Double-blind, Randomized, Controlled Trial. Journal of Psychiatric Practice 28:5, pages 373-382.
Crossref
Crossref
Prashant S. Giri, Firdosh Shah & Mitesh Kumar Dwivedi. 2022. Probiotics in the Prevention and Management of Human Diseases. Probiotics in the Prevention and Management of Human Diseases
161
186
.
Mahmoud Salami. 2022. Comprehensive Gut Microbiota. Comprehensive Gut Microbiota
253
279
.
Soumya Sundaram, Dinoop Korol Ponnambath & Sruthi S. Nair. 2022. Human Microbiome. Human Microbiome
147
167
.
Zakira Naureen, Saima Farooq, Tayyaba Zahoor & Syed Abdullah Gilani. 2022. Microbiome-Gut-Brain Axis. Microbiome-Gut-Brain Axis
383
399
.
Sílvia Cabré, Kenneth J. O’Riordan & John F. Cryan. 2022. Evolution, Biodiversity and a Reassessment of the Hygiene Hypothesis. Evolution, Biodiversity and a Reassessment of the Hygiene Hypothesis
339
392
.
Lady Johanna Forero-Rodríguez, Jonathan Josephs-Spaulding, Stefano Flor, Andrés Pinzón & Christoph Kaleta. (2021) Parkinson’s Disease and the Metal–Microbiome–Gut–Brain Axis: A Systems Toxicology Approach. Antioxidants 11:1, pages 71.
Crossref
Crossref
Yong Zhang, Xun Wei, Qian Sun, Weiyi Qian, Xinjie Liu, Jinping Li, Yan Long & Xiangyuan Wan. (2021) Different Types and Functional Effects of Probiotics on Human Health through Regulating Glucose Homeostasis. Journal of Agricultural and Food Chemistry 69:49, pages 14781-14791.
Crossref
Crossref
Joseph Allison, Aleksandra Kaliszewska, Sara Uceda, Manuel Reiriz & Natalia Arias. (2021) Targeting DNA Methylation in the Adult Brain through Diet. Nutrients 13:11, pages 3979.
Crossref
Crossref
Shahrzad Mirashrafi, Seyedeh Zahra Hejazi Taghanaki, Faezeh Sarlak, Amir Reza Moravejolahkami, Mohammad Ali Hojjati Kermani & Mohsen Haratian. (2021) Effect of probiotics supplementation on disease progression, depression, general health, and anthropometric measurements in relapsing‐remitting multiple sclerosis patients: A systematic review and meta‐analysis of clinical trials. International Journal of Clinical Practice 75:11.
Crossref
Crossref
Kontham Kulangara Varsha, Arun Padmakumar Maheshwari & Kesavan Madhavan Nampoothiri. (2021) Accomplishment of probiotics in human health pertaining to immunoregulation and disease control. Clinical Nutrition ESPEN 44, pages 26-37.
Crossref
Crossref
Lingling Huang, Chanisa Thonusin, Nipon Chattipakorn & Siriporn C. Chattipakorn. (2021) Impacts of gut microbiota on gestational diabetes mellitus: a comprehensive review. European Journal of Nutrition 60:5, pages 2343-2360.
Crossref
Crossref
Laura Ghezzi, Claudia Cantoni, Gabriela V. Pinget, Yanjiao Zhou & Laura Piccio. (2021) Targeting the gut to treat multiple sclerosis. Journal of Clinical Investigation 131:13.
Crossref
Crossref
Jinchi Jiang, Chuanqi Chu, Caie Wu, Chen Wang, Chengcheng Zhang, Tiantian Li, Qixiao Zhai, Leilei Yu, Fengwei Tian & Wei Chen. (2021) Efficacy of probiotics in multiple sclerosis: a systematic review of preclinical trials and meta-analysis of randomized controlled trials. Food & Function 12:6, pages 2354-2377.
Crossref
Crossref
Soudeh Ghafouri-Fard, Kasra Honarmand & Mohammad Taheri. (2021) A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis. Metabolic Brain Disease 36:3, pages 375-406.
Crossref
Crossref
Mahmoud Salami. (2021) Interplay of Good Bacteria and Central Nervous System: Cognitive Aspects and Mechanistic Considerations. Frontiers in Neuroscience 15.
Crossref
Crossref
Hao-Ming Xu, Hong-Li Huang, You-Lian Zhou, Hai-Lan Zhao, Jing Xu, Di-Wen Shou, Yan-Di Liu, Yong-Jian Zhou & Yu-Qiang Nie. (2021) Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain. Gastroenterology Research and Practice 2021, pages 1-20.
Crossref
Crossref
Nithin K. K, Prakash Patil, Satheesh Kumar Bhandary, Vikram Haridas, Suchetha Kumari N, Sarathkumar E & Praveenkumar Shetty. (2021) Is butyrate a natural alternative to dexamethasone in the management of CoVID-19?. F1000Research 10, pages 273.
Crossref
Crossref
Jiaqi Tong, Senthil Kumaran Satyanarayanan & Huanxing Su. (2020) Nutraceuticals and probiotics in the management of psychiatric and neurological disorders: A focus on microbiota-gut-brain-immune axis. Brain, Behavior, and Immunity 90, pages 403-419.
Crossref
Crossref
Virginia Sedeño Monge, Eduardo A Fabre Palacios, Cristina López García & María de L Meza Jiménez. (2020) Nutrientes y alimentos en la esclerosis múltiple. Archivos Latinoamericanos de Nutrición 70:1, pages 60-74.
Crossref
Crossref
Alexandra Reiter, Susanne A. Bengesser, Anne-Christin Hauschild, Anna-Maria Birkl-Töglhofer, Frederike T. Fellendorf, Martina Platzer, Tanja Färber, Matthias Seidl, Lilli-Marie Mendel, Renate Unterweger, Melanie Lenger, Sabrina Mörkl, Nina Dalkner, Armin Birner, Robert Queissner, Carlo Hamm, Alexander Maget, Rene Pilz, Alexandra Kohlhammer-Dohr, Jolana Wagner-Skacel, Kathrin Kreuzer, Helmut Schöggl, Daniela Amberger-Otti, Theresa Lahousen, Birgitta Leitner-Afschar, Johannes Haybäck, Hans-Peter Kapfhammer & Eva Reininghaus. (2020) Interleukin-6 Gene Expression Changes after a 4-Week Intake of a Multispecies Probiotic in Major Depressive Disorder—Preliminary Results of the PROVIT Study. Nutrients 12:9, pages 2575.
Crossref
Crossref
Natalie E Parks, Caitlin S Jackson-Tarlton, Laura Vacchi, Roah Merdad & Bradley C Johnston. (2020) Dietary interventions for multiple sclerosis-related outcomes. Cochrane Database of Systematic Reviews 2020:5.
Crossref
Crossref
Omid Reza Tamtaji, Tooba Hadinezhad, Maryam Fallah, Arash Rezaei Shahmirzadi, Mohsen Taghizadeh, Mohammad Behnam & Zatollah Asemi. (2020) The Therapeutic Potential of Quercetin in Parkinson’s Disease: Insights into its Molecular and Cellular Regulation. Current Drug Targets 21:5, pages 509-518.
Crossref
Crossref
John F Cryan, Kenneth J O'Riordan, Kiran Sandhu, Veronica Peterson & Timothy G Dinan. (2020) The gut microbiome in neurological disorders. The Lancet Neurology 19:2, pages 179-194.
Crossref
Crossref
Dawood Aghamohammadi, Hormoz Ayromlou, Neda Dolatkhah, Fatemeh Jahanjoo & Seyed Kazem Shakouri. (2019) The effects of probiotic Saccharomyces boulardii on the mental health, quality of life, fatigue, pain, and indices of inflammation and oxidative stress in patients with multiple sclerosis: study protocol for a double-blind randomized controlled clinical trial. Trials 20:1.
Crossref
Crossref
Mahtab Babadi, Ahmad Khorshidi, Esmat Aghadavood, Mansooreh Samimi, Elham Kavossian, Fereshteh Bahmani, Alireza Mafi, Rana Shafabakhsh, Mahbobeh Satari & Zatollah Asemi. (2018) The Effects of Probiotic Supplementation on Genetic and Metabolic Profiles in Patients with Gestational Diabetes Mellitus: a Randomized, Double-Blind, Placebo-Controlled Trial. Probiotics and Antimicrobial Proteins 11:4, pages 1227-1235.
Crossref
Crossref
Mahmoud Salami, Ebrahim Kouchaki, Zatollah Asemi & Omid Reza Tamtaji. (2019) How probiotic bacteria influence the motor and mental behaviors as well as immunological and oxidative biomarkers in multiple sclerosis? A double blind clinical trial. Journal of Functional Foods 52, pages 8-13.
Crossref
Crossref
Gislane Lellis Vilela de Oliveira. 2019. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications
325
332
.
L. Mestre, F.J. Carrillo-Salinas, M. Mecha, A. Feliú & C. Guaza. (2018) Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis. Biochemical Pharmacology 157, pages 51-66.
Crossref
Crossref
Carlos R Camara-Lemarroy, Luanne M Metz & V Wee Yong. (2018) Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome. World Journal of Gastroenterology 24:37, pages 4217-4223.
Crossref
Crossref
Azadeh Agahi, Gholam Ali Hamidi, Reza Daneshvar, Mostafa Hamdieh, Masoud Soheili, Azam Alinaghipour, Seyyed Mohammad Esmaeili Taba & Mahmoud Salami. (2018) Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial. Frontiers in Neurology 9.
Crossref
Crossref
Gislane L.V. de Oliveira. 2018. Probiotics - Current Knowledge and Future Prospects. Probiotics - Current Knowledge and Future Prospects.
Carlos R Camara-Lemarroy, Luanne Metz, Jonathan B Meddings, Keith A Sharkey & V Wee Yong. (2018) The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Brain 141:7, pages 1900-1916.
Crossref
Crossref